Porównaj metody

	Ocena Fugl-Meyer (FMA)	Skala Równowagi Berg (BBS)	NIHSS: National Institutes of Health Stroke Scale
Dziedzina	Rehabilitacja	Fizjoterapia	Neurologia
Rodzina	Process / pipeline	Process / pipeline	Process / pipeline
Rok powstania	1975	1989	1989
Twórca	Fugl-Meyer, Jääskö, Leyman	Katherine Berg	Thomas Brott and NIH Stroke Study Group
Typ	Performance-based clinical scale	Functional assessment scale	Clinician-rated
Źródło pierwotne	Fugl-Meyer, A. R., Jääskö, L., Leyman, I., Olsson, S., & Steglind, S. (1975). The post-stroke hemiplegic patient: a method for evaluation of physical performance. Scandinavian Journal of Rehabilitation Medicine, 7(2), 13–31.	Berg, K. O., Wood-Dauphinee, S. L., Williams, J. I., & Maki, B. (1992). Measuring balance in the elderly: Validation of an instrument. Canadian Journal of Public Health, 83(Suppl 2), S7-S11.	Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870.
Inne nazwy	FMA, Fugl-Meyer Scale, FMA Stroke	BBS	NIH Stroke Scale
Pokrewne	3	3	5
Podsumowanie	The Fugl-Meyer Assessment (FMA) is a comprehensive, clinician-administered scale measuring sensorimotor recovery and motor impairment in stroke patients. Developed by Fugl-Meyer and colleagues in 1975, FMA has become the gold standard outcome measure in stroke rehabilitation research and clinical practice for quantifying motor recovery in the upper extremity, lower extremity, balance, and sensation.	The Berg Balance Scale (BBS) is a 14-item performance-based assessment developed by Katherine Berg in 1989 to measure balance ability in older adults and individuals with neurological conditions. It evaluates static and dynamic balance through functional tasks relevant to daily living, providing a reliable and valid tool for fall risk assessment and rehabilitation monitoring.	The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.